Expression of osteocalcin and its transcriptional regulators Core- binding Factor alpha 1 and MSX2 in osteoid-forming tumours

Journal of Orthopaedic Research

Volumn 17, Issue 5, 1999, Pages 633-638

  Hopyan, S ^a   Gokgoz, N ^a   Bell, R S ^a   Andrulis, I L ^a   Alman, B A ^a   Wunder, J S ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; DNA; ENZYMES;

OSTEOCALCIN;

BONE;

OSTEOCALCIN; TRANSCRIPTION FACTOR;

ARTICLE; CONTROLLED STUDY; DNA BINDING; FIBROUS DYSPLASIA; HOMEOBOX; HUMAN; HUMAN TISSUE; OSSIFICATION; OSSIFYING MYOSITIS; OSTEOBLAST; OSTEOID; OSTEOID OSTEOMA; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; TRANSCRIPTION REGULATION;

EID: 0033197865     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.1100170503     Document Type: Article

References (26)

1. 1 Ali NN, Rowe J, Teich NM: Constitutive expression of non‐bone/liver/kidney alkaline phosphatase in human osteosarcoma cell lines. J Bone Miner Res 11: 512–520, 1996
2. 2 Bortell R, Owen TA, Shalhoub V, Heinrichs A, Aronow MA, Rochette‐Elgy C, Lutz Y, Stein JL, Lian JB, Stein GS: Constitutive transcription of the osteocalcin gene in osteosarcoma cells is reflected by altered protein‐DNA interactions at promoter regulatory elements. Proc Natl Acad Sci U S A 90: 2300–2304, 1993
3. 3 Chandar N, Campbell P, Novak J, Smith M: Dependence of induction of osteocalcin gene expression on the presence of wild‐type p53 in a murine osteosarcoma cell line. Mol Carcinog 8: 299–305, 1993
4. 4 Ducy P, Desbois C, Boyce B, Pinero G, Story B, Dunstan C, Smith E, Bonadio J, Goldstein S, Gundberg C, Bradley A, Karsenty G: Increased bone formation in osteocalcin‐deficient mice. Nature 382: 448–452, 1996
5. 5 Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G: Osf2/Cbfal: a transcriptional activator of osteoblast differentiation. Cell 89: 747–754, 1997
6. 6 Hoffmann HM, Catron KM, van Wijnen AJ, McCabe LR, Lian JB, Stein GS, Stein JL: Transcriptional control of the tissue‐specific, developmentally regulated osteocalcin gene requires a binding motif for the Msx family of homeodomain proteins. Proc Natl Acad Sci U S A 91: 12887–12891, 1994
7. 7 Huvos AG: Bone Tumors: Diagnosis, Treatment, and Prognosis, 2nd ed, pp 85–121, 745–753. Philadelphia, W. B. Saunders, 1991
8. 8 Jabs EW, Muller U, Li K, Ma L, Luo W, Haworth IS, Klisak I, Sparkes R, Warman ML, Mulliken JB, Snead ML, Maxson R: A mutation in the homeodomain of the human MSX2 gene in a family affected with autosomal dominant craniosynostosis. Cell 75: 443–450, 1993
9. 9 Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T: Targeted disruption of Cbfal results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89: 755–764, 1997
10. 10 Ladanyi M, Park CK, Lewis R, Jhanwar SC, Healey JH, Huvos AG: Sporadic amplification of the MYC gene in human osteosarcomas. Diagn Mol Pathol 2: 163–167, 1993
11. 11 Lee PD, Noble‐Topham SE, Bell RS, Andrulis IL: Quantitative analysis of multidrug resistance gene expression in human osteosarcomas. Br J Cancer 74: 1046–1050, 1996
12. 12 Mirra JM, Gold RH: Fibrous dysplasia. In: Bone Tumors: Clinical, Radiologic and Pathologic Correlations, pp 191–226. Ed by J Mirra, P Picci, and RH Bold. Philadelphia, Lea and Febiger, 1989
13. 13 Mundlos S, Otto F, Mundlos C, Mulliken JB, Aylsworth AS, Albright S, Lindhout D, Cole WG, Henn W, Knoll JH, Owen MJ, Mertelsmann R, Zabel BU, Olsen BR: Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 89: 773–779, 1997
14. 14 Newberry EP, Boudreaux JM, Towler DA: Stimulus‐selective inhibition of rat osteocalcin promoter induction and protein‐DNA interactions by the homeodomain Msx2. J Biol Chem 272: 29607–29613, 1997
15. 15 Noonan KE, Beck C, Holzmayer TA, Chin JE, Wunder JS, Andrulis IL, Gazdar AF, Willman CL, Griffith B, Von Hoff DD, Roninson IB: Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci U S A 87: 7160–7164, 1990
16. 16 Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T: Detection of polymorphisms of human DNA by gel electrophoresis as single‐strand conformation polymorphisms. Proc Natl Acad Sci U S A 86: 2766–2770, 1989
17. 17 Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GW, Beddington RS, Mundlos S, Olsen BR, Selby PB, Owen MJ: Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89: 765–771, 1997
18. 18 Rosenberg AE: Skeletal system and soft tissue tumors. In: Robbins Pathologic Basis of Disease, 5th ed, p 1236. Ed by RS Cotran, V Kumar, and SL Robbins, Philadelphia, W. B. Saunders, 1994
19. 19 Schiller AL: Bones and joints. In: Pathology, 2nd ed, p 1319. Ed by E Rubin and JL Farber. Philadelphia, J. B. Lippincott, 1994
20. 20 Serra M, Morini MC, Scotlandi K, Fisher LW, Zini N, Colombo MP, Campanacci M, Maraldi NM, Olivari S, Baldini N: Evaluation of osteonectin as a diagnostic marker of osteogenic bone tumors. Hum Pathol 23: 1326–1331, 1992
21. 21 Shafritz AB, Kaplan FS: Differential expression of bone and cartilage related genes in fibrodysplasia ossificans progressiva, myositis ossificans traumatica, and osteogenic sarcoma. Clin Orthop 346: 46–52, 1998
22. 22 Singer FR: Fibrous dysplasia of bone: the bone lesion unmasked. Am J Pathol 151: 1511–1515, 1997
23. 23 Stewart M, Terry A, Hu M, O'Hara M, Blyth K, Baxter E, Cameron E, Onions DE, Neil JC: Proviral insertions induce the expression of bone‐specific isoforms of PEBP2alphaA (CBFA1): evidence for a new myc collaborating oncogene. Proc Natl Acad Sci U S A 94: 8646–8651, 1997
24. 24 Toguchida J, Yamaguchi T, Dayton SH, Beauchamp RL, Herrera GE, Ishizaki K, Yamamuro T, Meyers PA, Little JB, Sasaki MS, Weichselbaum RR, Yandell DW: Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma. N Engl J Med 326: 1301–1308, 1992
25. 25 Towler DA, Rutledge SJ, Rodan GA: Msx‐2/Hox 8. 1: a transcriptional regulator of the rat osteocalcin promoter. Mol Endocrinol 8: 1484–1493, 1994
26. 26 Zhou H, Choong P, McCarthy R, Chou ST, Martin TJ, Ng KW: In situ hybridization to show sequential expression of osteoblast gene markers during bone formation in vivo. J Bone Miner Res 9: 1489–1499, 1994